DNMT2‐m5C‐ACLY Axis Promotes Lenvatinib Resistance in Hepatocellular Carcinoma Through Histone Acetylation‐Mediated Notch Pathway.
Saved in:
| Title: | DNMT2‐m5C‐ACLY Axis Promotes Lenvatinib Resistance in Hepatocellular Carcinoma Through Histone Acetylation‐Mediated Notch Pathway. |
|---|---|
| Authors: | Yang, Shiguang1,2 (AUTHOR), Li, Jie3 (AUTHOR), Mao, Shengwei1 (AUTHOR), Zhao, Xuhui1 (AUTHOR), Liu, Douwaner4 (AUTHOR), Chen, Jiafeng1 (AUTHOR), Fu, Jialu1 (AUTHOR), Bu, Yichao1 (AUTHOR), Wu, Xiaoling1 (AUTHOR), Liu, Shaoqing5 (AUTHOR), Yu, Qifeng6 (AUTHOR), Dong, Qiongzhu2 (AUTHOR) qzhdong@fudan.edu.cn, Tang, Zheng1 (AUTHOR) tang.zheng@zs-hospital.sh.cn, Fang, Yuan1 (AUTHOR) fangyuan1029@126.com, Shi, Yinghong1 (AUTHOR) shi.yinghong@zs-hospital.sh.cn |
| Source: | Advanced Science. 3/3/2026, Vol. 13 Issue 13, p1-16. 16p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
